X, M., Z, W., S, K., Y, Y., NA, D., Y, B., . . . G, L. (2026). The evolving global landscape of first-in-class oncology drug innovation. Signal transduction and targeted therapy, 11(1), . https://doi.org/10.1038/s41392-026-02606-7
Chicago Style (17th ed.) CitationX, Mao, Wang Z, Kong S, Yang Y, Dreyer NA, Ba Y, Lotze MT, Zhan Q, and Li G. "The Evolving Global Landscape of First-in-class Oncology Drug Innovation." Signal Transduction and Targeted Therapy 11, no. 1 (2026). https://doi.org/10.1038/s41392-026-02606-7.
MLA (9th ed.) CitationX, Mao, et al. "The Evolving Global Landscape of First-in-class Oncology Drug Innovation." Signal Transduction and Targeted Therapy, vol. 11, no. 1, 2026, https://doi.org/10.1038/s41392-026-02606-7.
Warning: These citations may not always be 100% accurate.